Krka wins atorvastatin patents lawsuit
This article was originally published in Scrip
A district court in Ljubljana, Slovenia, has stopped proceedings against Krka filed by Warner-Lambert and Pfizer. The two companies accused Krka of the infringement of their process patents EP0839132 and EP848705 for two forms of atorvastatin active ingredient. Although the district court's decision is not final, Warner-Lambert and Pfizer withdrew their lawsuit.